Evidence map›Paper›PMID 32916850›Full record

ArticleInternational journal of molecular sciences2020

Deletion of p53 and Hyper-Activation of PIK3CA in Keratin-15

Samantha M Y Chen, Bian Li, Andrew G Nicklawsky, Alexandra L Krinsky, Tonya Brunetti, Rachel A Woolaver, Xiaoguang Wang, Zhangguo Chen, Christian D Young, Dexiang Gao and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Samantha M Y ChenDepartment of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, School of Medicine, Aurora, CO 80045, USA.
Bian LiDepartment of Pathology, University of Colorado Anschutz Medical Campus, School of Medicine, Aurora, CO 80045, USA.
Andrew G NicklawskyDepartment of Pediatrics, Department of Biostatistics and Informatics, Cancer Center Biostatistics Core, University of Colorado Anschutz Medical Campus, School of Medicine, Aurora, CO 80045, USA.
Alexandra L KrinskyDepartment of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, School of Medicine, Aurora, CO 80045, USA.
Tonya BrunettiDepartment of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, School of Medicine, Aurora, CO 80045, USA.
Rachel A WoolaverDepartment of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, School of Medicine, Aurora, CO 80045, USA.
Xiaoguang WangDepartment of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, School of Medicine, Aurora, CO 80045, USA.
Zhangguo ChenDepartment of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, School of Medicine, Aurora, CO 80045, USA.
Christian D YoungDepartment of Pathology, University of Colorado Anschutz Medical Campus, School of Medicine, Aurora, CO 80045, USA.
Dexiang GaoDepartment of Pediatrics, Department of Biostatistics and Informatics, Cancer Center Biostatistics Core, University of Colorado Anschutz Medical Campus, School of Medicine, Aurora, CO 80045, USA.
Xiao-Jing WangDepartment of Pathology, University of Colorado Anschutz Medical Campus, School of Medicine, Aurora, CO 80045, USA.
Jing H WangDepartment of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, School of Medicine, Aurora, CO 80045, USA.ORCID 0000-0003-4343-2527
University of Colorado Anschutz Medical Campus · USVA Eastern Colorado Health Care System · US

Funding

University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0M
TRAINING PROGRAM IN IMMUNOLOGYT32AI007405 · NIAID · UNIVERSITY OF COLORADO DENVER · PI Laurel L Lenz, Raul Martin Torres · 1991 to 2026
$10.5M
Training in Translational Research of Lung, Head and Neck CancerT32CA174648 · NCI · UNIVERSITY OF COLORADO DENVER · PI KARAM, SANA D · 2013 to 2022
$4.2M
Elucidating Mechanism of Immune Evasion in Head and Neck CancersR01DE027329 · NIDCR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI WANG, JING HONG, WANG, XIAO-JING · 2018 to 2022
$2.8M
Mechanisms of Dual Inhibition of TGFbeta/PD-L1 in HNSCCR01DE028420 · NIDCR · UNIVERSITY OF COLORADO DENVER · PI WANG, JING HONG, WANG, XIAO-JING · 2019 to 2023
$2.7M
Mechanisms underlying therapy failure of immune checkpoint inhibitors and Notch1 loss-mediated immunosuppression in head and neck cancersF31DE027854 · NIDCR · UNIVERSITY OF COLORADO DENVER · PI WOOLAVER, RACHEL A · 2018 to 2020
$100k
American Cancer Society ACS IRG #16-184-56National Institute of Allergy and Infectious Diseases T32-AI007405NCI NIH HHS P30CA046934NCI NIH HHS T32 CA174648NIDCR NIH HHS F31 DE027854NIDCR NIH HHS F31DE027854NIDCR NIH HHS R01 DE027329NIDCR NIH HHS R01-DE027329NIDCR NIH HHS R01 DE028420NIDCR NIH HHS R01-DE028420
6 · The paper itself

Abstract

Squamous cell carcinoma (SCC) is the second commonest type of skin cancer, and SCCs make up about 90% of head and neck cancers (HNSCCs). HNSCCs harbor two frequent molecular alterations, namely, gain-of-function alterations of phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (

Indexed as

Genes, p53AnimalsCarcinoma, Squamous CellClass I Phosphatidylinositol 3-KinasesHead and Neck NeoplasmsHumansKeratin-15Lymphocytes, Tumor-InfiltratingMice, TransgenicNeoplasms, ExperimentalTumor MicroenvironmentClass I Phosphatidylinositol 3-KinasesKeratin-15Krt15 protein, mousePIK3CA protein, humanPik3ca protein, mousecancer immunotherapyhead and neck cancerstumor infiltrating lymphocytestumor microenvironment

Identifiers

PMID32916850
PMCPMC7554792
OpenAlexW3084361883

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.